Background: We intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.

Methods: A total of 135 ASA I-III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized. Low dose group (Group L): Remimazolam besylate 0.2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.3 mg/kg; High dose group (Group H): Remimazolam besylate 0.4 mg/kg. There were 45 patients in each group. The blood pressure, heart rate, BIS values, cardiac function before induction (T), after induction (T) and after intubation (T), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded.

Results: At T and T, systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences ( < 0.05). At T and T, the BIS value in Group M was lower than that in Group L, with a statistically significant difference ( < 0.05). However, there was no statistically significant difference (  005) in BIS values between Group M and Group H; At T and T, the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences ( < 0.05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences ( < 0.05). The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences ( < 0.05).

Conclusions: General anesthesia induction with remimazolam besylate at 0.3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743649PMC
http://dx.doi.org/10.3389/fcvm.2024.1453608DOI Listing

Publication Analysis

Top Keywords

remimazolam besylate
16
cardiac function
12
dose group
12
group group
12
group remimazolam
12
group
10
effects doses
8
doses remimazolam
8
quality sedation
8
sedation cardiac
8

Similar Publications

Background: We intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.

Methods: A total of 135 ASA I-III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared the effectiveness and safety of remimazolam besylate to ciprofol in elderly patients during painless gastrointestinal endoscopy.
  • Patients were divided into a control group (ciprofol) and an observation group (remimazolam besylate) to analyze various factors like anesthesia onset time, recovery time, hemodynamics, and cognitive function.
  • Results indicated that remimazolam besylate provided quicker anesthesia and recovery, more effective analgesia, better hemodynamic stability, and less cognitive impairment, with no significant difference in adverse reactions between the two groups.
  • Overall, remimazolam besylate was found to be a superior choice for elderly patients in this procedure.
View Article and Find Full Text PDF
Article Synopsis
  • Thyroid surgery requiring nerve monitoring often needs deeper sedation, which can cause blood pressure instability.
  • A study is comparing remimazolam, a new sedative, with propofol to see which better supports stable hemodynamics during surgery.
  • The trial will randomly assign 284 patients to either sedative, focusing on outcomes like hypotension and the overall safety of each sedative combination.
View Article and Find Full Text PDF

Comparison of the anesthetic effects of remimazolam tosilate and remimazolam besylate in daytime hysteroscopic surgery.

BMC Anesthesiol

October 2024

Department of Anesthesiology, Weifang People's Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang, 261041, China.

Article Synopsis
  • The study aimed to compare the anesthetic effects of two forms of remimazolam (tositlate and besylate) in patients undergoing daytime hysteroscopic surgery.
  • Fifty patients were randomly divided into two groups to evaluate differences in induction doses and various anesthesia-related outcomes.
  • Results showed no significant differences between the two groups in terms of anesthesia induction, recovery time, and adverse effects, indicating both forms have similar anesthetic effects.
View Article and Find Full Text PDF

Remimazolam besylate is a novel, rapid-onset, ultra-short-acting benzodiazepine with an advantageous cardio-respiratory safety profile. To date, there have been few published reports of remimazolam-induced anaphylaxis, none of which are documented in patients with mast cell disease. We describe the case of a 77-year-old male with oncologic mastocytosis who developed anaphylaxis following remimazolam administration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!